Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05047965 · ClinicalTrials.gov registry record · Early Phase 1

An Investigational Scan (MRI With Dixon Based Sequences) in Detecting Prostate Cancer

A Early Phase 1 study of Prostate Carcinoma, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
Early Phase 1
Development phase
65
Enrollment target
1
Study location

NCT05047965 is a Early Phase 1 study of Prostate Carcinoma that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 65 participants, below the 1,501-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05047965, a Early Phase 1 study of Prostate Carcinoma, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
Early Phase 1
Development phase
65 participants
Enrollment target
1
Study location

Study Summary

This trial studies the use of magnetic resonance imaging (MRI) with Dixon based imaging sequences in detecting prostate cancer. MRI uses radio waves and a powerful magnet linked to a computer to create detailed pictures of areas inside the body. Researchers hope to learn if using a modified MRI scan technique with Dixon based imaging sequencing will help to produce better images of prostate cancer than the standard of care MRI scan technique.

Conditions Studied

Prostate Carcinoma

Interventions

  • PROCEDURE Magnetic Resonance Imaging
  • PROCEDURE Dixon MRI

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2013-04-25
Est. Completion 2027-02-02
Phase Early Phase 1

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05047965

The ClinicalTrials.gov registry entry for NCT05047965 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,501-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (96% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which Magnetic Resonance Imaging is the first listed.

NCT05047965 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05047965 about?

NCT05047965 is a clinical study titled "An Investigational Scan (MRI With Dixon Based Sequences) in Detecting Prostate Cancer". This trial studies the use of magnetic resonance imaging (MRI) with Dixon based imaging sequences in detecting prostate cancer. MRI uses radio waves and a powerful magnet linked to a computer to create detailed pictures of areas inside the body. Researchers hope to learn if using a modified MRI scan...

What is the current status of trial NCT05047965?

This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 65 participants. The study started on 2013-04-25. Estimated completion is 2027-02-02.

What conditions does trial NCT05047965 study?

This clinical trial studies the following conditions: Prostate Carcinoma.

What interventions are being tested in trial NCT05047965?

The interventions under investigation include: Magnetic Resonance Imaging (PROCEDURE), Dixon MRI (PROCEDURE).

Who is sponsoring clinical trial NCT05047965?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05047965 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Carcinoma

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.